vs
Side-by-side financial comparison of ASTRONICS CORP (ATRO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $240.1M, roughly 1.2× ASTRONICS CORP). On growth, ASTRONICS CORP posted the faster year-over-year revenue change (15.1% vs -6.4%). Over the past eight quarters, ASTRONICS CORP's revenue compounded faster (13.9% CAGR vs 4.2%).
Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
ATRO vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $240.1M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | 33.3% | 64.6% |
| Operating Margin | 14.8% | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | 15.1% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $0.82 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $240.1M | $295.9M | ||
| Q3 25 | $211.4M | — | ||
| Q2 25 | $204.7M | $317.0M | ||
| Q1 25 | $205.9M | $316.2M | ||
| Q4 24 | $208.5M | $297.0M | ||
| Q3 24 | $203.7M | $289.5M | ||
| Q2 24 | $198.1M | $306.1M | ||
| Q1 24 | $185.1M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-11.1M | — | ||
| Q2 25 | $1.3M | $-17.7M | ||
| Q1 25 | $9.5M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $-11.7M | $33.6M | ||
| Q2 24 | $1.5M | $40.6M | ||
| Q1 24 | $-3.2M | $49.1M |
| Q4 25 | 33.3% | 64.6% | ||
| Q3 25 | 30.5% | — | ||
| Q2 25 | 25.8% | 62.7% | ||
| Q1 25 | 29.5% | 67.9% | ||
| Q4 24 | 29.8% | 65.3% | ||
| Q3 24 | 27.1% | 63.2% | ||
| Q2 24 | 28.0% | 66.4% | ||
| Q1 24 | 25.7% | 67.4% |
| Q4 25 | 14.8% | 18.4% | ||
| Q3 25 | 10.9% | — | ||
| Q2 25 | 2.3% | -7.5% | ||
| Q1 25 | 6.4% | 12.2% | ||
| Q4 24 | 4.3% | 16.0% | ||
| Q3 24 | 4.1% | 13.8% | ||
| Q2 24 | 3.8% | 15.0% | ||
| Q1 24 | 0.9% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -5.2% | — | ||
| Q2 25 | 0.6% | -5.6% | ||
| Q1 25 | 4.6% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | -5.8% | 11.6% | ||
| Q2 24 | 0.8% | 13.3% | ||
| Q1 24 | -1.7% | 16.2% |
| Q4 25 | $0.82 | $0.24 | ||
| Q3 25 | $-0.31 | — | ||
| Q2 25 | $0.04 | $-0.11 | ||
| Q1 25 | $0.26 | $0.14 | ||
| Q4 24 | $-0.07 | $0.22 | ||
| Q3 24 | $-0.34 | $0.21 | ||
| Q2 24 | $0.04 | $0.26 | ||
| Q1 24 | $-0.09 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.2M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $140.1M | $2.0B |
| Total Assets | $706.7M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $172.9M | ||
| Q3 25 | $13.5M | — | ||
| Q2 25 | $13.5M | $162.2M | ||
| Q1 25 | $24.8M | $140.7M | ||
| Q4 24 | $9.3M | $177.5M | ||
| Q3 24 | $5.2M | $187.5M | ||
| Q2 24 | $2.9M | $152.9M | ||
| Q1 24 | $5.3M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $140.1M | $2.0B | ||
| Q3 25 | $108.9M | — | ||
| Q2 25 | $271.6M | $1.9B | ||
| Q1 25 | $266.8M | $2.0B | ||
| Q4 24 | $256.1M | $2.1B | ||
| Q3 24 | $249.2M | $2.1B | ||
| Q2 24 | $257.9M | $2.1B | ||
| Q1 24 | $251.7M | $2.0B |
| Q4 25 | $706.7M | $2.5B | ||
| Q3 25 | $682.2M | — | ||
| Q2 25 | $646.7M | $2.6B | ||
| Q1 25 | $662.2M | $2.6B | ||
| Q4 24 | $648.8M | $2.7B | ||
| Q3 24 | $651.6M | $2.7B | ||
| Q2 24 | $644.9M | $2.7B | ||
| Q1 24 | $630.0M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $27.6M | — |
| Free Cash FlowOCF − Capex | $15.8M | — |
| FCF MarginFCF / Revenue | 6.6% | — |
| Capex IntensityCapex / Revenue | 4.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.6M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $-7.6M | $98.2M | ||
| Q1 25 | $20.6M | $41.1M | ||
| Q4 24 | $26.4M | $84.3M | ||
| Q3 24 | $8.4M | $63.9M | ||
| Q2 24 | $-6.3M | $75.5M | ||
| Q1 24 | $2.0M | $81.0M |
| Q4 25 | $15.8M | — | ||
| Q3 25 | $21.0M | — | ||
| Q2 25 | $-12.2M | $93.3M | ||
| Q1 25 | $18.5M | $31.0M | ||
| Q4 24 | $23.2M | $77.5M | ||
| Q3 24 | $6.5M | $54.7M | ||
| Q2 24 | $-8.1M | $57.5M | ||
| Q1 24 | $439.0K | $64.5M |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | -6.0% | 29.4% | ||
| Q1 25 | 9.0% | 9.8% | ||
| Q4 24 | 11.1% | 26.1% | ||
| Q3 24 | 3.2% | 18.9% | ||
| Q2 24 | -4.1% | 18.8% | ||
| Q1 24 | 0.2% | 21.3% |
| Q4 25 | 4.9% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 2.2% | 1.5% | ||
| Q1 25 | 1.0% | 3.2% | ||
| Q4 24 | 1.5% | 2.3% | ||
| Q3 24 | 0.9% | 3.2% | ||
| Q2 24 | 0.9% | 5.9% | ||
| Q1 24 | 0.9% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -5.81× | — | ||
| Q1 25 | 2.17× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | -4.08× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |